PRENW Prenetics Global Ltd
Price Chart
Executive Summary
Prenetics Global (PRENW) filed its Q1 2026 6-K, reporting revenue of $36.0M, with IM8 revenue of $33.8M up 23.1% sequentially and nearly 6x YoY from $5.7M. The company raised full-year 2026 IM8 guidance to $190M-$210M and projected Q2 2026 revenue of $46M-$48M. The net loss of $23.1M included non-cash losses from warrant liabilities and digital asset markdowns.
Actionable Insight
IM8 revenue growth is accelerating sharply (33% sequential quarterly guidance) with expanding gross margins and strong cash position. The raised guidance and record monthly revenue in May support the growth thesis. Watch Q2 actuals against $46-48M guidance for confirmation of trajectory; the shift to quarterly subscriptions increases average order value and upfront cash flow.
Key Facts
- Q1 2026 revenue of $36.0M, up from $8.3M YoY (continuing ops, reflecting IM8 growth)
- IM8 revenue of $33.8M in Q1 2026 vs $5.7M in Q1 2025 and $27.4M in Q4 2025
- IM8 monthly revenue reached record $16.7M in May 2026, implying ~$200M annualized recurring revenue
- Full-year 2026 IM8 revenue guidance raised to $190M-$210M from $180M-$200M
- Q2 2026 revenue guided to $46M-$48M with IM8 contributing $44M-$46M
- Gross margin improved to 65% from 68% YoY (IM8 margin 64% vs 60% QoQ)
- Adjusted EBITDA loss of $5.6M vs $2.4M in Q1 2025
- Net loss of $23.1M included $9.8M unrealized loss on digital assets and $8.0M warrant liability fair-value loss (non-cash)
- Cash and cash equivalents $56.0M at March 31, 2026; no debt; pro forma liquidity ~$139.7M as of May 31, 2026
- Fully divested digital asset holdings for $41.3M post-quarter
- Repurchased 968,349 shares for ~$19M under $40M buyback program
Financial Impact
Q1 2026 continuing ops revenue of $36.0M vs $8.3M YoY; IM8 revenue $33.8M vs $5.7M YoY. Guidance implies FY2026 IM8 revenue of ~$200M midpoint.
Risk Factors
- Selling and marketing expenses rose to $22.2M from $4.1M YoY, consuming 62% of revenue — sustainability unclear as IM8 scales
- Adjusted EBITDA loss widened to $5.6M from $2.4M YoY despite revenue growth
- CircleDNA segment revenue declined to $2.2M from $2.5M YoY with gross margin compression (72% vs 86%)
- Net loss of $23.1M included material non-cash items but operating cash flow still negative at -$12.1M
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-042070 |
| Document: a6-kx2026q1.htm | 0001628280-26-042070 |
| Document: 0001628280-26-042070-index-headers.html | 0001628280-26-042070 |
| Document: 0001628280-26-042070-index.html | 0001628280-26-042070 |
| Document: 0001628280-26-042070.txt | 0001628280-26-042070 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
3d ago
|
6-K
| $0.0195 awaiting T+1 | awaiting T+1 | — | $0.0195 (+0.00%) |
|
Jun 4, 2026
9d ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▲ +2.60% | $0.0195 (+0.00%) |
|
May 20, 2026
24d ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▼ −0.19% | $0.0195 (+0.00%) |
|
May 14, 2026
4w ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▲ +1.23% | $0.0195 (+0.00%) |
|
May 14, 2026
4w ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▲ +1.23% | $0.0195 (+0.00%) |
|
May 4, 2026
5w ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▼ −0.80% | $0.0195 (+0.00%) |
|
Apr 2, 2026
10w ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▼ −0.48% | $0.0195 (+0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access